Suppr超能文献

基于序列的分型方法的小型测试:B*1520等位基因的定义

A small test of a sequence-based typing method: definition of the B*1520 allele.

作者信息

Domena J D, Little A M, Arnett K L, Adams E J, Marsh S G, Parham P

机构信息

Department of Cell Biology, Stanford University, CA.

出版信息

Tissue Antigens. 1994 Oct;44(4):217-24. doi: 10.1111/j.1399-0039.1994.tb02386.x.

Abstract

Santamaria et al. (Human Immunology 1993 37: 39-50) describe a method of sequence-based typing (SBT) for HLA-A, B and C alleles said to give "unambiguous typing of any sample, heterozygous or homozygous, without requiring additional typing information". From SBT analysis, which involves determination of partial sequences of mixed alleles, these investigators reported that cell lines KT17 (HLA-B35,62) and OLGA (HLA-B62) from the reference panel of the 10th International Histocompatibility Workshop express novel variants of HLA-B15 (B1501-MN6) and HLA-B35 (B3501-MN7) respectively. To study further the novel alleles, we cloned and sequenced full-length HLA-B cDNA clones isolated from the KT17 and OLGA cell lines. We find that KT17 expresses B3501, as assigned by SBT, and B1501, the common allele encoding the B62 antigen. We were unable to confirm that KT17 expresses the novel B1501-MN6 variant identified by SBT. For OLGA our analysis confirms the partial sequences obtained by SBT. Thus OLGA expresses B1501 and a novel HLA-B allele. The complete sequence of the latter shows it is a hybrid having exons 1 and 2 in common with B1501 and other B15 subtypes and exons 3-7 in common with B3501 and related molecules including B5301 and B5801. The novel allele has been designated B1520 because of its sequence similarity with the B15 group; furthermore, serological analysis shows that the B1520 product does not express epitopes in common with either B35, B53 or B58. The B1520 heavy chain has a similar isoelectric point to A3101; B1520 was undetected by previous applications of isoelectric focusing because B*1520 and A31 are both expressed by OLGA. In conclusion, HLA-B typing of two cell lines by cDNA cloning and sequencing gives concordant results with SBT for three of the four alleles. The cause of the discrepancy for the fourth allele is unknown, however, this finding indicates that the novel HLA-A, B and C sequences emerging from SBT studies need independent verification.

摘要

圣玛丽亚等人(《人类免疫学》,1993年,第37卷,第39 - 50页)描述了一种用于HLA - A、B和C等位基因的基于序列的分型方法(SBT),据说该方法能“对任何样本进行明确分型,无论其是杂合子还是纯合子,无需额外的分型信息”。通过SBT分析(该分析涉及确定混合等位基因的部分序列),这些研究人员报告称,来自第10届国际组织相容性研讨会参考样本库的细胞系KT17(HLA - B35,62)和OLGA(HLA - B62)分别表达了HLA - B15(B1501 - MN6)和HLA - B35(B3501 - MN7)的新型变体。为了进一步研究这些新型等位基因,我们克隆并测序了从KT17和OLGA细胞系中分离出的全长HLA - B cDNA克隆。我们发现,KT17如SBT所指定的那样表达B3501以及编码B62抗原的常见等位基因B1501。我们无法证实KT17表达SBT所鉴定出的新型B1501 - MN6变体。对于OLGA,我们的分析证实了SBT所获得的部分序列。因此,OLGA表达B1501和一个新型HLA - B等位基因。后者的完整序列表明它是一个杂合子,其外显子1和2与B1501及其他B15亚型相同,外显子3 - 7与B3501及包括B5301和B5801在内的相关分子相同。由于其与B15组的序列相似性,该新型等位基因被命名为B1520;此外,血清学分析表明,B1520产物不表达与B35、B53或B58共有的表位。B1520重链的等电点与A3101相似;由于OLGA同时表达B1520和A31,所以在先前的等电聚焦应用中未检测到B*1520。总之,通过cDNA克隆和测序对两个细胞系进行HLA - B分型,在四个等位基因中的三个上与SBT结果一致。然而,第四个等位基因出现差异的原因尚不清楚,不过这一发现表明,SBT研究中出现的新型HLA - A、B和C序列需要独立验证。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验